News Daily News PCI Radiation Dose in Germany Has Nose-dived, but Gains Are Patchy L.A. McKeown January 24, 2022
News Features Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path Michael O'Riordan January 17, 2022
News Daily News Hearts, Lungs, Kidneys: Mild-to-Moderate COVID-19 Leaves a Mark Caitlin E. Cox January 14, 2022
News Daily News As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control Caitlin E. Cox January 10, 2022
News Daily News Statins No Benefit to ICU-Admitted COVID-19 Patients: INSPIRATION-S Caitlin E. Cox January 07, 2022
News Daily News Progress Against Acute MI Deaths in Nonelderly US Adults Has Plateaued L.A. McKeown December 30, 2021
News Daily News AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD Caitlin E. Cox December 28, 2021
News Daily News FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels Michael O'Riordan December 22, 2021
News Daily News For Angina Patients, Language Barriers Can Complicate CVD Care Caitlin E. Cox December 20, 2021
News Daily News Discharge Safe as Early as a Day After Primary PCI for STEMI L.A. McKeown December 15, 2021
News Daily News British Medical Groups Express Concern About Inclisiran Rollout Michael O'Riordan December 14, 2021
News Daily News Cardiopulmonary Tests Urged for Lasting Fatigue, Dyspnea After COVID-19 Todd Neale December 02, 2021
News Daily News Select COVID-19 Patients May Benefit From Postdischarge Anticoagulation Todd Neale November 25, 2021
News Conference News AHA 2021 ApoB Gains Ground as Best Lipid Predictor of MI Risk Michael O'Riordan November 22, 2021
News Conference News AHA 2021 Dietary Patterns, Social Pressures: AHA Offers New Nutrition Advice Caitlin E. Cox November 19, 2021
News Conference News AHA 2021 No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials Todd Neale November 15, 2021
News Conference News AXIOMATIC-TKR: Milvexian Promising for VTE Prevention L.A. McKeown November 15, 2021